Tricot, T.; Thibaut, H.J.; Abbasi, K.; Boon, R.; Helsen, N.; Kumar, M.; Neyts, J.; Verfaillie, C.
Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings. Biomedicines 2022, 10, 268.
https://doi.org/10.3390/biomedicines10020268
AMA Style
Tricot T, Thibaut HJ, Abbasi K, Boon R, Helsen N, Kumar M, Neyts J, Verfaillie C.
Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings. Biomedicines. 2022; 10(2):268.
https://doi.org/10.3390/biomedicines10020268
Chicago/Turabian Style
Tricot, Tine, Hendrik Jan Thibaut, Kayvan Abbasi, Ruben Boon, Nicky Helsen, Manoj Kumar, Johan Neyts, and Catherine Verfaillie.
2022. "Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings" Biomedicines 10, no. 2: 268.
https://doi.org/10.3390/biomedicines10020268
APA Style
Tricot, T., Thibaut, H. J., Abbasi, K., Boon, R., Helsen, N., Kumar, M., Neyts, J., & Verfaillie, C.
(2022). Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings. Biomedicines, 10(2), 268.
https://doi.org/10.3390/biomedicines10020268